Firms using nanomaterials in cosmetics should consider conducting clinical studies as part of the premarket safety assessment for such products, FDA indicates in a guidance document issued April 20.
In the guidance, titled “Safety of Nanomaterials in Cosmetic Products,” the agency notes that generally its expectations for the cosmetics...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?